key: cord-0896453-ykvrkpwu
authors: Yousafzai, Zaland A; Qayyum, Wajeeha; Amin, Qazi Kamran; Shafiq, Ihtesham; Anthony, Nouman
title: Thrombotic Sequela of Asymptomatic COVID-19 Infection
date: 2021-12-25
journal: Cureus
DOI: 10.7759/cureus.20673
sha: 4136f66504cf24ada5853eac9906b33b2995f2d1
doc_id: 896453
cord_uid: ykvrkpwu

Severe coronavirus disease 2019 (COVID-19) is known to be associated with thrombotic events like ischemic stroke. However, in the case of mild or asymptomatic disease, a thrombotic event like ischemic stroke is rare and has never been reported in our country. We present the case of a 28-year-old male patient with no co-morbidities who was diagnosed to have ischemic stroke involving the basilar artery. No risk factors for ischemic stroke could be found except for post-COVID-19 status, evident by the presence of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It presents with a wide variety of symptoms, the most frequent of which are fever, fatigue, myalgias, dry cough, and in some severe cases, shortness of breath which may progress to respiratory failure and acute respiratory distress syndrome [1] . Thrombotic complications like pulmonary embolism, deep vein thrombosis, ischemic stroke, myocardial infarction, and systemic arterial embolism are well known to be associated with symptomatic and severe disease [2] . Their association with mild or asymptomatic disease has not been mentioned in the literature. As per our knowledge, no cases of ischemic stroke following asymptomatic SARS-CoV-2 infection have been reported from Pakistan. Here we report a case of a basilar artery infarction secondary to asymptomatic COVID-19 in a young male with no co-morbidities.

A 28-year-old non-smoker male presented to the emergency department with a sudden loss of consciousness; he had no history of hypertension, diabetes, illicit drug use, recent trauma, fall, fits, or fever. Family history was negative for sudden deaths, early-onset strokes, and cardiovascular disease. On presentation, he was vitally and hemodynamically stable with a blood pressure of 117/73 mmHg, heart rate of 76 bpm, and O 2 saturation of 98% on room air. On physical examination, his Glasgow Coma Scale (GCS) score was 8/15 (E4 M3 V1). He had decorticate posturing on painful stimuli. Power in all the limbs was hard to assess; deep tendon reflexes were brisk and symmetrical bilaterally, and planters showed extensor response bilaterally. No facial droop or asymmetry was noted, and gag reflex was present. He was completely mute, non-responsive to any command. His eyes were deviated in abducted position. Voluntary movements of eyes were absent in all directions. His pupils were bilaterally dilated and non-reactive to light (≈ 6 mm). Oculocephalic reflex was absent; however, oculovestibular reflex was present.

An MRI of the brain done in the emergency room showed multiple small scattered acute cerebral infarcts affecting the midbrain and pons, bilateral thalami (territory of artery of Percheron), right parietal lobe, central aspect of cerebellar hemisphere along with loss of signal void in the basilar artery ( Figure 1 ). On a magnetic resonance angiogram (MRA) of the brain, loss of normal flow void was noted in the basilar artery ( Figure 2 ). To determine the cause of ischemic stroke in this young male serial investigations were performed, including complete blood counts, C-reactive protein levels, renal and liver function tests, (postprandial) lipid profile, echocardiography, 24-hour Holter monitoring, and carotid doppler ( Table 1) . Specialized investigations, including a urine toxicology screening, erythrocyte sedimentation rate (ESR), antinuclear antibodies, thyroid function tests, syphilis screening, homocysteine levels, and thrombophilia screening, were done, which turned out to be negative ( Table 1) . Keeping in view the ongoing COVID-19 pandemic, SARS-CoV-2 antibodies were sent for, which turned out to be high, while the polymerase chain reaction (PCR) test for COVID-19 was negative twice, and no changes were observed on X-ray and CT scan of the chest. The high values of the initial biochemical test were due to dehydration which was corrected with intravenous fluids, and the values were normal on peripheral smear; hence hematologic malignancies and polycythemia were ruled out. A detailed history taken from an immediate relative living with the patient did not reveal any symptoms of the disease in the past, nor had he received any COVID-19 vaccine. After excluding all potential causes for basilar artery thrombosis in this patient, it was attributed to a hypercoagulable state secondary to asymptomatic SARS-COV-2 infection. The patient's condition remained static over the following two weeks, and the patient was shifted to a long-term care facility for future nursing care. 

Ischemic stroke is a known neurological sequela in patients admitted with COVID-19; a study from China revealed that 5.7% of patients admitted with severe COVID-19 developed cerebrovascular accidents compared with 0.8% of patients with the mild disease [3] . Other studies have also reported ischemic stroke occurring in young individuals with COVID-19, but in both cases, the cerebrovascular accidents were preceded by symptomatic COVID-19 [4, 5] . Our patient got a stroke as a sequela of asymptomatic SARS-CoV-2 infection in the past. Comorbidities increase the risk of ischemic stroke after COVID-19 [6] ; however, our patient had no comorbidities. A retrospective cohort study from New York reported that COVID-19 patients with high D-dimers had a higher frequency (65.6%) of disabling stroke [7] . Although our patient had a high score on the National Institutes of Health Stroke Scale (NIHSS) on arrival, his D-dimers were normal. A number of mechanisms are proposed for the development of thrombotic events in SARS-CoV-2 infected patients; high D-dimer levels in patients with severe infection can be secondary to exaggerated inflammatory processes termed sepsis-induced coagulopathy (SIC) [8] . The presence of antiphospholipid antibodies has also been described in some cases [9] . Vasculopathy caused by the direct neuroinvasive potential of the virus has also been proposed [6] . In our patient, the mechanism remains unclear. It may be due to damage of vascular endothelium by virus remnants or autoantibodies that led to the thrombus formation leading to stroke.

It is very unusual to have serious and disabling sequelae of a disease that itself had an asymptomatic course. In our case, treatment options were limited due to the late presentation of the patient with limited facilities. Prophylactic strategy in the setting of asymptomatic infection is also not applicable. These types of case scenarios are such where the physician and patient both are helpless.

Human subjects: Consent was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges

Thrombotic complications of COVID-19 infection: a review

Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China

Massive ischemic strokes in a young patient with severe coronavirus disease 2019 pneumonia

Large-vessel stroke as a presenting feature of Covid-19 in the young

COVID-19 and stroke: incidental, triggered or causative

SARS-CoV-2 and stroke in a New York healthcare system . Stroke. 2020

COVID-19-related stroke

Coagulopathy and antiphospholipid antibodies in patients with Covid-19